Schedule

Lecture faculty as of February 9

• Carolyn J. Anderson, University of Pittsburgh Medical Center, Pittsburgh, PA 
  An overview of oncological imaging

• Stephen B. Baylin, Johns Hopkins University School of Medicine, Baltimore, MD
  The cancer epigenome: Its origins, contributions to tumorigenesis and translational implications

• J. Michael Bishop, University of California, San Francisco, CA
  Applying cancer genomics

• Alan D. D’Andrea, Dana-Farber Cancer Institute, Boston, MA
  Targeting DNA repair pathways in cancer therapy

• James R. Downing, St. Jude Children’s Research Hospital, Memphis, TN
  Molecular pathology of acute leukemia

• Mark W. Geraci, University of Colorado Denver Medical Center, Aurora, CO
  Lung cancer chemoprevention: A translational tale

• William G. Kaelin Jr., Dana-Farber Cancer Institute, Boston, MA
  Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: Implications for oxygen sensing

• Jennifer A. Pietenpol, Vanderbilt-Ingram Cancer Center, Nashville, TN
  From the p53 signaling axis to molecular targets and therapeutic approaches for triple negative breast cancer

• Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY
  Overcoming resistance to targeted therapies

• William R. Sellers, Novartis Institutes for BioMedical Research, Cambridge, MA
  The discovery and application of effective cancer therapeutics

• Kevin M. Shannon, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
  Targeting aberrant Ras signaling in cancer

• Suzanne L. Topalian, Johns Hopkins Kimmel Comprehensive Cancer Center, Baltimore, MD
  The PD-1 pathway in cancer immunotherapy

• David A. Tuveson, Cancer Research UK, Cambridge, United Kingdom
  Modeling human cancer in mice
  

Laboratory faculty as of February 9

• Camilla Heinzmann, QIAGEN Inc., Valencia, CA
  Tools for Successful Gene Expression Analysis: From RNA to Real-Time RT-PCR

• Thomas Graeber, University of California, Los Angeles, CA, and Parag Mallick, Stanford University, Palo Alto, CA
  Protein Purification and Subfractionation for Proteomic Characterization

• Robert A. Sclafani, University of Colorado Health Sciences Center, Aurora, CO
  Genetic Systems for Analyzing the Role of Interacting Proteins in Cancer Cells

• Tyra Wolfsberg and Gretchen Gibney, National Human Genome Research Institute, Bethesda, MD
  Bioinformatics 101